Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1) Antibody (HRP)

Este producto es parte de KIR3DL - Killer cell immunoglobulin-like receptor 3DL
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1) Antibody (HRP)
category
Primary Antibodies
provider
Abbexa
reference
abx316996
tested applications
ELISA

Description

KIR3DL1 Antibody (HRP) is a Rabbit Polyclonal against KIR3DL1 conjugated to HRP.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
HRP
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P43629
Gene ID
3811
NCBI Accession
NP_001309097.1, NM_001322168.1, NP_037421.2, NM_013289.2
OMIM
604946
Alias
CD158 antigen-like family member E,HLA-BW4-specific inhibitory NK cell receptor,CD158E,NKAT3,NKB1Natural killer-associated transcript 3,KIR,NKB1,NKAT3,NKB1B,NKAT-3,CD158E1,KIR2DL5B,KIR3DL1/S1
Background
Antibody anti-KIR3DL1
Status
RUO

Descripción

Killer Cell Immunoglobulin-Like Receptor 3DL1 (KIR3DL1) is a member of the KIR family, expressed on natural killer (NK) cells and a subset of T lymphocytes, playing a critical role in modulating immune responses. This receptor binds specifically to HLA class I molecules, particularly HLA-B alleles with the Bw4 motif, allowing NK cells to recognize and monitor the health of target cells. When KIR3DL1 engages its ligand, it delivers inhibitory signals that suppress NK cell cytotoxic activity, thus maintaining immune homeostasis and preventing autoreactivity. Variations in KIR3DL1, including polymorphisms and expression levels, are associated with differential susceptibility to infectious diseases, cancer, and autoimmune conditions. Studies have also highlighted its significance in allogeneic hematopoietic stem cell transplantation, where KIR-HLA mismatches can influence graft-versus-leukemia effects and transplantation outcomes. By regulating NK cell activity, KIR3DL1 contributes to the delicate balance between immune surveillance and tolerance, making it a valuable target for therapeutic interventions in cancer immunotherapy and immune-mediated disorders.

Related Products

EH9634

Human KIR3DL1 (Killer cell immunoglobulin-like receptor 3DL1) ELISA Kit

Ver Producto
FNab04583

KIR3DL1 antibody

Receptor on natural killer(NK) cells for HLA Bw4 allele. Inhibits the activity of NK cells thus preventing cell lysis.

Ver Producto
P5207

Recombinant Human KIR3DL1

Ver Producto